Resultados da busca - Lacey E. Dobrolecki

Refinar Resultados
  1. 1
    C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes

    C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes por Kuppusamy Balamurugan, Daniel Mendoza-Villanueva, Shikha Sharan, Glenn H. Summers, Lacey E. Dobrolecki, Michael T. Lewis, Esta Sterneck

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Quantitative Serum Glycomics of Esophageal Adenocarcinoma and Other Esophageal Disease Onsets

    Quantitative Serum Glycomics of Esophageal Adenocarcinoma and Other Esophageal Disease Onsets por Yehia Mechref, Ahmed Hussein, Slávka Bekešová, Vitara Pungpapong, Min Zhang, Lacey E. Dobrolecki, Robert J. Hickey, Zane T. Hammoud, Miloš V. Novotný

    Publicado em 2009
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells

    Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells por Tomonori Tanei, Dong Soon Choi, Angel Rodriguez, Diana H. Liang, Lacey E. Dobrolecki, Madhumita Ghosh, Melissa D. Landis, Jenny C. Chang

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Alterations in the Serum Glycome Due to Metastatic Prostate Cancer

    Alterations in the Serum Glycome Due to Metastatic Prostate Cancer por Zuzana Kyseľová, Yehia Mechref, Mohammad M. Al Bataineh, Lacey E. Dobrolecki, Robert J. Hickey, Jake Vinson, Christopher J. Sweeney, Miloš V. Novotný

    Publicado em 2007
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles

    Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles por Zuzana Kyseľová, Yehia Mechref, Pilsoo Kang, John A. Goetz, Lacey E. Dobrolecki, George W. Sledge, Lauren A. Schnaper, Robert J. Hickey, Linda H. Malkas, Miloš V. Novotný

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model

    Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model por Bhuvanesh Dave, Melissa D. Landis, Lacey E. Dobrolecki, Meng-Fen Wu, Xiaomei Zhang, Thomas F. Westbrook, Susan G. Hilsenbeck, Dan Liu, Michael T. Lewis, David J. Tweardy, Jenny C. Chang

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas

    Genomic and epigenomic <i>BRCA</i> alterations predict adaptive resistance and response to platinum-based therapy in patients with triple-negative breast and ovarian carcinomas por Francesca Menghi, Kalyan Banda, Pooja Kumar, Robert F. Straub, Lacey E. Dobrolecki, Isabel V. Rodriguez, Susan E. Yost, Harshpreet Chandok, Marc R. Radke, George Somlo, Yuan Yuan, Michael T. Lewis, Elizabeth M. Swisher, Edison T. Liu

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer

    Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer por Uddalak Bharadwaj, T. Kris Eckols, Mikhail Kolosov, Moses M. Kasembeli, Ammar Adam, David Torres, X. Zhang, Lacey E. Dobrolecki, Wenjie Wei, Michael T. Lewis, Bhuvanesh Dave, Judy C. Chang, Melissa D. Landis, Chad J. Creighton, Michael A. Mancini, David J. Tweardy

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker

    A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker por Linda H. Malkas, Brittney-Shea Herbert, Waleed Abdel‐Aziz, Lacey E. Dobrolecki, Yang Liu, Beamon Agarwal, Derek J. Hoelz, Sunil Badve, Lauren A. Schnaper, Randy J. Arnold, Yehia Mechref, Miloš V. Novotný, Patrick J. Loehrer, Robert J. Goulet, Robert J. Hickey

    Publicado em 2006
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors

    Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors por Anne F. Schott, Melissa D. Landis, Gabriela Dontu, Kent A. Griffith, Rachel M. Layman, Ian E. Krop, Lacey A. Paskett, Helen Wong, Lacey E. Dobrolecki, Michael T. Lewis, Amber M. Froehlich, Jaya Paranilam, Daniel F. Hayes, Max S. Wicha, Jenny C. Chang

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming

    Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming por Lin Tian, Amit Goldstein, Hai Wang, Hin Ching Lo, Ik Sun Kim, Thomas Welte, Kuanwei Sheng, Lacey E. Dobrolecki, Xiaomei Zhang, Nagireddy Putluri, Thuy L. Phung, Sendurai A. Mani, Fabio Stossi, Arun Sreekumar, Michael A. Mancini, William K. Decker, Chenghang Zong, Michael T. Lewis, Xiang H.-F. Zhang

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer

    Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer por Tyler Risom, Ellen M. Langer, Margaret P. Chapman, Juha Rantala, Andrew J. Fields, Christopher Boniface, Mariano J. Alvarez, Nicholas D. Kendsersky, Carl Pelz, Katherine Johnson-Camacho, Lacey E. Dobrolecki, Koei Chin, Anil Aswani, Nicholas J. Wang, Andrea Califano, Michael T. Lewis, Claire J. Tomlin, Paul T. Spellman, Andrew Adey, Joe W. Gray, Rosalie C. Sears

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer

    A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer por Hariprasad Thangavel, Carmine De Angelis, Suhas Vasaikar, Raksha R. Bhat, Mohit Kumar Jolly, Chandandeep Nagi, Chad J. Creighton, Fengju Chen, Lacey E. Dobrolecki, Jason T. George, Tanya Kumar, Noor Mazin Abdulkareem, Sufeng Mao, Agostina Nardone, Mothaffar F. Rimawi, C. Kent Osborne, Michael T. Lewis, Herbert Levine, Bing Zhang, Rachel Schiff, Mario Giuliano, Meghana V. Trivedi

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis

    Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis por Mario Giuliano, Sabrina Herrera, Pavel Christiny, Chad A. Shaw, Chad J. Creighton, Tamika Mitchell, Raksha R. Bhat, Xiaomei Zhang, Sufeng Mao, Lacey E. Dobrolecki, Ahmed Al-Rawi, Fengju Chen, Bianca Maria Veneziani, Xiang H.-F. Zhang, Susan G. Hilsenbeck, Alejandro Contreras, Carolina Gutiérrez, Rinath Jeselsohn, Mothaffar F. Rimawi, C. Kent Osborne, Michael T. Lewis, Rachel Schiff, Meghana V. Trivedi

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer

    TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer por Tiara T. Byrd, Kristen Fousek, Antonella Pignata, Christopher Szot, Heba Samaha, Steven Seaman, Lacey E. Dobrolecki, Vita S. Salsman, Htoo Zarni Oo, Kevin Bielamowicz, Daniel Landi, Nino Rainusso, John Hicks, Suzanne Z. Powell, Matthew L. Baker, Winfried S. Wels, Joachim Koch, Poul H. Sorensen, Benjamin Deneen, Matthew J. Ellis, Michael T. Lewis, Meenakshi Hegde, Bradley S. Fletcher, Brad St. Croix, Nabil Ahmed

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer

    Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer por Jun Hyoung Park, Sajna Antony Vithayathil, Santosh Kumar, Pi‐Lin Sung, Lacey E. Dobrolecki, Vasanta Putluri, Vadiraja B. Bhat, Salil Kumar Bhowmik, Vineet K. Gupta, Kavisha Arora, Danli Wu, Efrosini Tsouko, Yiqun Zhang, Suman Kumar Maity, Taraka Donti, Brett H. Graham, Daniel E. Frigo, Cristian Coarfa, Patricia Yotnda, Nagireddy Putluri, Arun Sreekumar, Michael T. Lewis, Chad J. Creighton, Lee-Jun Wong, Benny Abraham Kaipparettu

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway

    Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway por Jun Hyoung Park, K.H. Jung, Dongya Jia, Sukjin Yang, Kuldeep S. Attri, Songyeon Ahn, Divya Murthy, Tagari Samanta, Debasmita Dutta, Meron Ghidey, Somik Chatterjee, Seung Yeop Han, Diego A. Pedroza, Abha Tiwari, Joyce V. Lee, Caitlin M. Davis, Shuting Li, Vasanta Putluri, Chad J. Creighton, Nagireddy Putluri, Lacey E. Dobrolecki, Michael T. Lewis, Jeffrey M. Rosen, José N. Onuchic, Andrei Goga, Benny Abraham Kaipparettu

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation

    Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation por Thomas Welte, Ik Sun Kim, Lin Tian, Xia Gao, Hai Wang, June Li, Xue B. Holdman, Jason I. Herschkowitz, Adam C. Pond, Guorui Xie, Sarah J. Kurley, Tuan M. Nguyen, Lan Liao, Lacey E. Dobrolecki, Lan Pang, Qianxing Mo, Dean P. Edwards, Shixia Huang, Xin Li, Jianming Xu, Yi Li, Michael T. Lewis, Tian Wang, Thomas F. Westbrook, Jeffrey M. Rosen, Xiang H.-F. Zhang

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer

    The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer por Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yuntao Yang, Yuen San Chan, Danthasinghe Waduge Badrajee Piyarathna, Lacey E. Dobrolecki, David Shih, Zhongcheng Shi, Jun Xu, Shixia Huang, Matthew J. Ellis, Andrea B. Apolo, Leomar Y. Ballester, Jianjun Gao, Donna E. Hansel, Yair Lotan, H. Courtney Hodges, Seth P. Lerner, Chad J. Creighton, Arun Sreekumar, W. Jim Zheng, Pavlos Msaouel, Shyam M. Kavuri, Nagireddy Putluri

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models por Xiaomei Zhang, Sofie Claerhout, Aleix Prat, Lacey E. Dobrolecki, Ivana Petrović, Qing Lai, Melissa D. Landis, Lisa Wiechmann, Rachel Schiff, Mario Giuliano, Helen Wong, Suzanne A.W. Fuqua, Alejandro Contreras, Carolina Gutiérrez, Jian Huang, Sufeng Mao, Anne C. Pavlick, Amber M. Froehlich, Meng-Fen Wu, Anna Tsimelzon, Susan G. Hilsenbeck, Edward S. Chen, Pavel Zuloaga, Chad A. Shaw, Mothaffar F. Rimawi, Charles M. Perou, Gordon B. Mills, Jenny C. Chang, Michael T. Lewis

    Publicado em 2013
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: